Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenström Macroglobulinemia
Clinical trial NCT02844361 · COMPLETED
Trial details
- NCT number
- NCT02844361
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2019-11-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.